+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Spiriva"

SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Dry Powder Inhaler Market Report 2025 - Product Thumbnail Image

Dry Powder Inhaler Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Bronchodilators Market Report 2025 - Product Thumbnail Image

Bronchodilators Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
Spiriva - Product Thumbnail Image

Spiriva

  • Report
  • July 2018
  • 33 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Spiriva is a respiratory drug used to treat chronic obstructive pulmonary disease (COPD). It is a long-acting bronchodilator that works by relaxing the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both capsule and inhaler form. Spiriva is typically prescribed to patients with COPD who have difficulty breathing due to narrowing of the airways. It is also used to prevent flare-ups of COPD symptoms. Spiriva is a popular drug in the respiratory market, with many generic and branded versions available. It is often prescribed in combination with other medications to treat COPD. It is also used to treat asthma, although it is not approved for this indication. The companies in the Spiriva market include Boehringer Ingelheim, Pfizer, GlaxoSmithKline, Merck, and AstraZeneca. Show Less Read more